25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Opyl Ltd
Buy, Hold or Sell?

Let's analyze Opyl together

I guess you are interested in Opyl Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Opyl Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Opyl Ltd

I send you an email if I find something interesting about Opyl Ltd.

1. Quick Overview

1.1. Quick analysis of Opyl (30 sec.)










1.2. What can you expect buying and holding a share of Opyl? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.01
Return On Investment
45.9%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.016 - A$0.024
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Opyl (5 min.)




Live pricePrice per Share (EOD)
A$0.02
Intrinsic Value Per Share
A$-0.16 - A$-0.07
Total Value Per Share
A$-0.16 - A$-0.07

2.2. Growth of Opyl (5 min.)




Is Opyl growing?

Current yearPrevious yearGrowGrow %
How rich?-$59.7k-$267.6k$207.8k347.6%

How much money is Opyl making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$1.1m-$931.1k-44.9%
Net Profit Margin-787.2%-279.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Opyl (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#91 / 108

Most Revenue
#96 / 108

Most Profit
#61 / 108

Most Efficient
#101 / 108
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Opyl?

Welcome investor! Opyl's management wants to use your money to grow the business. In return you get a share of Opyl.

First you should know what it really means to hold a share of Opyl. And how you can make/lose money.

Speculation

The Price per Share of Opyl is A$0.016. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opyl.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opyl, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opyl.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-76.0%-0.01-76.0%-0.01-41.9%-0.01-43.8%-0.01-58.0%
Usd Book Value Change Per Share0.007.6%0.007.6%0.00-16.3%0.001.5%0.00-14.2%
Usd Dividend Per Share0.000.0%0.000.0%0.0023.3%0.0012.9%0.0020.9%
Usd Total Gains Per Share0.007.6%0.007.6%0.007.0%0.0014.4%0.006.6%
Usd Price Per Share0.02-0.02-0.02-0.05-0.03-
Price to Earnings Ratio-1.36--1.36--2.26--10.48--5.47-
Price-to-Total Gains Ratio13.62-13.62-13.59-10.03-5.61-
Price to Book Ratio-47.34--47.34--9.69-2.10-2.02-
Price-to-Total Gains Ratio13.62-13.62-13.59-10.03-5.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0106112
Number of shares94240
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (94240 shares)114.75217.33
Gains per Year (94240 shares)458.99869.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1045944977892859
2091890815561831728
301377136723332752597
401836182631113663466
502295228538894584335
602754274446675495204
703213320354446416073
803672366262227336942
904131412170008247811
1004590458077789168680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.026.00.07.1%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%16.012.00.057.1%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%5.00.05.050.0%5.00.023.017.9%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%17.011.00.060.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Opyl Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0020.0020%-0.004+314%0.000+401%-0.003+287%
Book Value Per Share---0.001-0.0010%-0.002+348%0.003-117%0.004-113%
Current Ratio--0.7730.7730%0.611+26%3.030-74%5.203-85%
Debt To Asset Ratio--1.2191.2190%1.569-22%0.774+57%0.715+71%
Debt To Equity Ratio----0%-0%0.622-100%0.541-100%
Dividend Per Share----0%0.006-100%0.003-100%0.005-100%
Eps---0.018-0.0180%-0.010-45%-0.011-42%-0.014-24%
Free Cash Flow Per Share---0.012-0.0120%-0.008-34%-0.008-33%-0.011-13%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.002+326%0.002-130%0.001-163%
Gross Profit Margin--1.0001.0000%1.017-2%1.027-3%1.020-2%
Intrinsic Value_10Y_max---0.068--------
Intrinsic Value_10Y_min---0.161--------
Intrinsic Value_1Y_max---0.008--------
Intrinsic Value_1Y_min---0.012--------
Intrinsic Value_3Y_max---0.023--------
Intrinsic Value_3Y_min---0.040--------
Intrinsic Value_5Y_max---0.037--------
Intrinsic Value_5Y_min---0.072--------
Market Cap2731440.128-56%4267875.2004267875.2000%3909373.683+9%12813868.500-67%7496242.828-43%
Net Profit Margin---7.872-7.8720%-2.794-65%-3.192-59%-22.046+180%
Operating Margin---6.800-6.8000%-3.773-45%-3.514-48%-21.949+223%
Operating Ratio--14.80214.8020%4.773+210%5.914+150%24.620-40%
Pb Ratio-30.295+36%-47.337-47.3370%-9.687-80%2.097-2358%2.015-2449%
Pe Ratio-0.873+36%-1.363-1.3630%-2.265+66%-10.477+668%-5.472+301%
Price Per Share0.016-56%0.0250.0250%0.023+9%0.075-67%0.043-42%
Price To Free Cash Flow Ratio-1.317+36%-2.057-2.0570%-2.861+39%-11.882+478%-6.314+207%
Price To Total Gains Ratio8.715-56%13.61713.6170%13.590+0%10.033+36%5.613+143%
Quick Ratio--0.7620.7620%0.611+25%3.011-75%4.790-84%
Return On Assets---7.605-7.6050%-2.433-68%-2.723-64%-3.546-53%
Return On Equity----0%-0%-1.9240%-3.1900%
Total Gains Per Share--0.0020.0020%0.002+9%0.003-47%0.002+15%
Usd Book Value---59794.112-59794.1120%-267658.235+348%355482.760-117%493829.000-112%
Usd Book Value Change Per Share--0.0010.0010%-0.003+314%0.000+401%-0.002+287%
Usd Book Value Per Share--0.0000.0000%-0.002+348%0.002-117%0.003-113%
Usd Dividend Per Share----0%0.004-100%0.002-100%0.003-100%
Usd Eps---0.012-0.0120%-0.007-45%-0.007-42%-0.009-24%
Usd Free Cash Flow---1375732.795-1375732.7950%-906284.686-34%-926554.332-33%-1239727.785-10%
Usd Free Cash Flow Per Share---0.008-0.0080%-0.005-34%-0.005-33%-0.007-13%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.001+326%0.001-130%0.000-163%
Usd Market Cap1811491.093-56%2830454.8332830454.8330%2592696.627+9%8498157.590-67%4971508.244-43%
Usd Price Per Share0.011-56%0.0170.0170%0.015+9%0.050-67%0.028-42%
Usd Profit---2076064.037-2076064.0370%-1144905.372-45%-1195290.400-42%-1919362.610-8%
Usd Revenue--263712.858263712.8580%409795.922-36%438568.722-40%330672.581-20%
Usd Total Gains Per Share--0.0010.0010%0.001+9%0.002-47%0.001+15%
 EOD+1 -7MRQTTM+0 -0YOY+17 -175Y+6 -2910Y+11 -24

3.3 Fundamental Score

Let's check the fundamental score of Opyl Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.873
Price to Book Ratio (EOD)Between0-1-30.295
Net Profit Margin (MRQ)Greater than0-7.872
Operating Margin (MRQ)Greater than0-6.800
Quick Ratio (MRQ)Greater than10.762
Current Ratio (MRQ)Greater than10.773
Debt to Asset Ratio (MRQ)Less than11.219
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-7.605
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Opyl Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.271
Ma 20Greater thanMa 500.018
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.021
OpenGreater thanClose0.016
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Opyl Ltd

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

Fundamental data was last updated by Penke on 2024-11-06 06:40:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Opyl earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • A Net Profit Margin of -787.2% means that $-7.87 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Opyl Ltd:

  • The MRQ is -787.2%. The company is making a huge loss. -2
  • The TTM is -787.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-787.2%TTM-787.2%0.0%
TTM-787.2%YOY-279.4%-507.9%
TTM-787.2%5Y-319.2%-468.1%
5Y-319.2%10Y-2,204.6%+1,885.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-787.2%-19.5%-767.7%
TTM-787.2%-21.7%-765.5%
YOY-279.4%-17.8%-261.6%
5Y-319.2%-29.9%-289.3%
10Y-2,204.6%-34.1%-2,170.5%
4.3.1.2. Return on Assets

Shows how efficient Opyl is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • -760.5% Return on Assets means that Opyl generated $-7.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Opyl Ltd:

  • The MRQ is -760.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -760.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-760.5%TTM-760.5%0.0%
TTM-760.5%YOY-243.3%-517.3%
TTM-760.5%5Y-272.3%-488.3%
5Y-272.3%10Y-354.6%+82.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-760.5%-4.1%-756.4%
TTM-760.5%-4.0%-756.5%
YOY-243.3%-4.5%-238.8%
5Y-272.3%-4.8%-267.5%
10Y-354.6%-5.2%-349.4%
4.3.1.3. Return on Equity

Shows how efficient Opyl is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • 0.0% Return on Equity means Opyl generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Opyl Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-192.4%+192.4%
5Y-192.4%10Y-319.0%+126.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.4%+2.4%
TTM--4.2%+4.2%
YOY--5.4%+5.4%
5Y-192.4%-7.9%-184.5%
10Y-319.0%-8.4%-310.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Opyl Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Opyl is operating .

  • Measures how much profit Opyl makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • An Operating Margin of -680.0% means the company generated $-6.80  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Opyl Ltd:

  • The MRQ is -680.0%. The company is operating very inefficient. -2
  • The TTM is -680.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-680.0%TTM-680.0%0.0%
TTM-680.0%YOY-377.3%-302.7%
TTM-680.0%5Y-351.4%-328.6%
5Y-351.4%10Y-2,194.9%+1,843.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-680.0%-12.2%-667.8%
TTM-680.0%-19.0%-661.0%
YOY-377.3%-17.8%-359.5%
5Y-351.4%-14.8%-336.6%
10Y-2,194.9%-21.1%-2,173.8%
4.3.2.2. Operating Ratio

Measures how efficient Opyl is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 14.80 means that the operating costs are $14.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Opyl Ltd:

  • The MRQ is 14.802. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.802. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.802TTM14.8020.000
TTM14.802YOY4.773+10.029
TTM14.8025Y5.914+8.888
5Y5.91410Y24.620-18.706
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8021.273+13.529
TTM14.8021.281+13.521
YOY4.7731.376+3.397
5Y5.9141.283+4.631
10Y24.6201.311+23.309
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Opyl Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Opyl is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.77 means the company has $0.77 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Opyl Ltd:

  • The MRQ is 0.773. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.773. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.773TTM0.7730.000
TTM0.773YOY0.611+0.162
TTM0.7735Y3.030-2.257
5Y3.03010Y5.203-2.173
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7731.660-0.887
TTM0.7731.712-0.939
YOY0.6111.939-1.328
5Y3.0302.644+0.386
10Y5.2032.637+2.566
4.4.3.2. Quick Ratio

Measures if Opyl is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • A Quick Ratio of 0.76 means the company can pay off $0.76 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Opyl Ltd:

  • The MRQ is 0.762. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.762. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.762TTM0.7620.000
TTM0.762YOY0.611+0.151
TTM0.7625Y3.011-2.248
5Y3.01110Y4.790-1.780
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7621.192-0.430
TTM0.7621.214-0.452
YOY0.6111.415-0.804
5Y3.0112.266+0.745
10Y4.7902.342+2.448
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Opyl Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Opyl assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opyl to Health Information Services industry mean.
  • A Debt to Asset Ratio of 1.22 means that Opyl assets are financed with 121.9% credit (debt) and the remaining percentage (100% - 121.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Opyl Ltd:

  • The MRQ is 1.219. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.219. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.219TTM1.2190.000
TTM1.219YOY1.569-0.350
TTM1.2195Y0.774+0.445
5Y0.77410Y0.715+0.060
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2190.414+0.805
TTM1.2190.406+0.813
YOY1.5690.415+1.154
5Y0.7740.423+0.351
10Y0.7150.428+0.287
4.5.4.2. Debt to Equity Ratio

Measures if Opyl is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opyl to the Health Information Services industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Opyl Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.622-0.622
5Y0.62210Y0.541+0.081
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.574-0.574
TTM-0.578-0.578
YOY-0.619-0.619
5Y0.6220.631-0.009
10Y0.5410.649-0.108
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Opyl generates.

  • Above 15 is considered overpriced but always compare Opyl to the Health Information Services industry mean.
  • A PE ratio of -1.36 means the investor is paying $-1.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Opyl Ltd:

  • The EOD is -0.873. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.363. Based on the earnings, the company is expensive. -2
  • The TTM is -1.363. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.873MRQ-1.363+0.491
MRQ-1.363TTM-1.3630.000
TTM-1.363YOY-2.265+0.901
TTM-1.3635Y-10.477+9.114
5Y-10.47710Y-5.472-5.006
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-0.873-0.876+0.003
MRQ-1.363-1.016-0.347
TTM-1.363-1.591+0.228
YOY-2.265-2.227-0.038
5Y-10.477-3.921-6.556
10Y-5.472-3.744-1.728
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Opyl Ltd:

  • The EOD is -1.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.057. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.057. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.317MRQ-2.057+0.741
MRQ-2.057TTM-2.0570.000
TTM-2.057YOY-2.861+0.803
TTM-2.0575Y-11.882+9.824
5Y-11.88210Y-6.314-5.568
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.317-1.176-0.141
MRQ-2.057-1.223-0.834
TTM-2.057-1.167-0.890
YOY-2.861-3.956+1.095
5Y-11.882-6.762-5.120
10Y-6.314-4.171-2.143
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Opyl is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of -47.34 means the investor is paying $-47.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Opyl Ltd:

  • The EOD is -30.295. Based on the equity, the company is expensive. -2
  • The MRQ is -47.337. Based on the equity, the company is expensive. -2
  • The TTM is -47.337. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-30.295MRQ-47.337+17.041
MRQ-47.337TTM-47.3370.000
TTM-47.337YOY-9.687-37.650
TTM-47.3375Y2.097-49.433
5Y2.09710Y2.015+0.082
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-30.2951.774-32.069
MRQ-47.3371.752-49.089
TTM-47.3371.764-49.101
YOY-9.6872.235-11.922
5Y2.0973.926-1.829
10Y2.0154.200-2.185
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Opyl Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -67-10-7715-6124-38446



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets412
Total Liabilities502
Total Stockholder Equity-90
 As reported
Total Liabilities 502
Total Stockholder Equity+ -90
Total Assets = 412

Assets

Total Assets412
Total Current Assets388
Long-term Assets24
Total Current Assets
Cash And Cash Equivalents 375
Net Receivables 8
Other Current Assets 5
Total Current Assets  (as reported)388
Total Current Assets  (calculated)388
+/-0
Long-term Assets
Property Plant Equipment 18
Long-term Assets Other 6
Long-term Assets  (as reported)24
Long-term Assets  (calculated)24
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities502
Long-term Liabilities0
Total Stockholder Equity-90
Total Current Liabilities
Accounts payable 237
Other Current Liabilities 265
Total Current Liabilities  (as reported)502
Total Current Liabilities  (calculated)502
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock22,502
Retained Earnings -23,727
Accumulated Other Comprehensive Income 1,135
Total Stockholder Equity (as reported)-90
Total Stockholder Equity (calculated)-90
+/-0
Other
Cash and Short Term Investments 375
Common Stock Shares Outstanding 170,715
Liabilities and Stockholders Equity 412
Net Debt -375
Net Working Capital -114



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-30
> Total Assets 
6,775
6,371
6,500
7,106
9,670
9,606
10,347
10,824
18,641
14,774
53,833
80,187
412
1,709
15,689
10,275
8,611
5,941
1,350
2,440
629
2,034
330
936
2,502
979
710
412
4127109792,5029363302,0346292,4401,3505,9418,61110,27515,6891,70941280,18753,83314,77418,64110,82410,3479,6069,6707,1066,5006,3716,775
   > Total Current Assets 
3,570
572
119
266
1,440
161
255
127
1,364
309
37,308
20,106
380
1,677
5,137
3,110
1,874
869
471
2,366
583
1,861
330
869
2,426
918
672
388
3886729182,4268693301,8615832,3664718691,8743,1105,1371,67738020,10637,3083091,3641272551611,4402661195723,570
       Cash And Cash Equivalents 
3,481
564
109
167
1,416
144
231
117
1,017
286
37,259
18,536
239
1,663
5,102
3,064
1,854
852
367
2,299
494
1,546
99
800
2,316
786
453
375
3754537862,316800991,5464942,2993678521,8543,0645,1021,66323918,53637,2592861,0171172311441,4161671095643,481
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
25
16
17
24
0
0
0
0
0
00000241716258000000000000000000
       Net Receivables 
89
2
1
38
20
7
23
0
337
14
49
1,505
141
14
35
43
20
17
4
48
57
145
133
61
98
124
219
8
821912498611331455748417204335141411,5054914337023720381289
       Other Current Assets 
0
6
9
60
4
10
10
10
10
10
0
65
0
0
0
4
0
13
100
44
73
154
98
8
11
8
214
5
5214811898154734410013040006501010101010460960
   > Long-term Assets 
3,205
5,799
6,381
6,840
8,230
9,445
10,093
10,697
17,276
14,464
16,525
60,081
32
32
10,552
7,165
6,737
5,072
879
75
40
167
58
67
77
61
38
24
24386177675816740758795,0726,7377,16510,552323260,08116,52514,46417,27610,69710,0939,4458,2306,8406,3815,7993,205
       Property Plant Equipment 
3,205
5,699
6,291
1
8,190
9,405
10,053
10,657
17,236
14,437
16,498
31,716
0
0
10,500
7,111
6,715
5,049
857
29
15
5
0
9
19
21
14
18
1814211990515298575,0496,7157,11110,5000031,71616,49814,43717,23610,65710,0539,4058,19016,2915,6993,205
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
0
0
0
0
0
0
000000162000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
15,677
15,677
0
0
0
0
0
30
68
45
25
0
58
58
58
41
23
0
023415858580254568300000015,67715,6770000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
6
-58
0
0
0
0
0
00000-586500000000000000000000
> Total Liabilities 
622
162
83
700
255
712
499
354
2,552
1,364
1,703
20,580
4,451
21
1,522
152
297
167
25
222
398
640
733
217
315
712
1,113
502
5021,113712315217733640398222251672971521,522214,45120,5801,7031,3642,55235449971225570083162622
   > Total Current Liabilities 
622
162
83
700
255
612
478
354
2,552
1,364
1,703
6,567
4,451
21
1,522
152
297
167
25
186
398
618
733
217
289
677
1,100
502
5021,100677289217733618398186251672971521,522214,4516,5671,7031,3642,55235447861225570083162622
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
1,267
738
0
0
0
0
0
57
839
0
63
103
204
0
0
132
300
0
03001320020410363083957000007381,2670000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204
0
0
0
300
0
03000002040000000000000000000000
       Accounts payable 
589
143
53
675
229
0
454
336
2,093
527
419
5,775
4,451
21
22
152
269
137
5
74
42
51
185
58
53
175
194
237
2371941755358185514274513726915222214,4515,7754195272,093336454022967553143589
       Other Current Liabilities 
33
19
30
25
27
612
24
18
459
837
17
54
0
0
1,500
0
29
29
20
111
356
568
295
158
235
371
575
265
26557537123515829556835611120292901,50000541783745918246122725301933
   > Long-term Liabilities 
0
0
0
0
0
101
21
0
0
0
0
14,013
0
0
0
0
0
0
0
36
0
22
438
58
26
35
13
0
01335265843822036000000014,01300002110100000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
0
0
26
35
13
0
01335260022000000000000000000000
> Total Stockholder Equity
6,153
6,209
6,417
6,406
9,415
8,893
9,848
10,470
16,089
13,410
52,130
59,607
-4,039
1,688
14,167
10,122
8,314
5,774
1,325
2,219
231
1,394
-403
719
2,188
267
-404
-90
-90-4042672,188719-4031,3942312,2191,3255,7748,31410,12214,1671,688-4,03959,60752,13013,41016,08910,4709,8488,8939,4156,4066,4176,2096,153
   Common Stock
18,347
20,057
22,824
10,857
14,374
14,534
15,990
17,400
24,015
28,187
69,124
77,975
83,966
2,545
14,042
14,036
14,034
14,032
14,032
8,607
9,850
13,673
14,827
16,837
19,271
19,271
19,918
22,502
22,50219,91819,27119,27116,83714,82713,6739,8508,60714,03214,03214,03414,03614,0422,54583,96677,97569,12428,18724,01517,40015,99014,53414,37410,85722,82420,05718,347
   Retained Earnings -23,727-20,966-19,371-17,411-17,003-16,306-13,201-10,166-6,937-13,084-8,608-7,375-5,517-2,146-1,824-91,877-19,228-17,719-14,777-7,926-6,929-6,142-5,640-4,959-4,451-3,829-3,444-2,646
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
-9,548
-10,506
-12,681
90
95
100
102
0
0
0
0
0
0
0
0
0
0
0
-35
549
546
922
0
885
328
367
644
0
06443673288850922546549-35000000000001021009590-12,681-10,506-9,548



5.4. Balance Sheets

All numbers in thousands.